Listed

Capricor Therapeutics, Inc.

CAPRNasdaqCIK 1133869HealthcareFiscal year ends Dec 31

Reports and events: 339 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Capricor Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2024-02-2916:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-24-002183
2024-01-1109:00 ET8-K8.01 Other events0001558370-24-000197
2023-12-1116:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-23-019717
2023-11-1417:16 ET10-QQuarterly reportPeriod 2023-09-300001558370-23-019065
2023-11-1416:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-23-019019
2023-09-2917:00 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-23-016171
2023-09-2907:30 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001558370-23-016149
2023-09-0609:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001558370-23-015482
2023-08-0808:01 ET10-QQuarterly reportPeriod 2023-06-300001558370-23-013763
2023-08-0716:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-23-013590
2023-07-2408:35 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001558370-23-012106
2023-07-1308:31 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001558370-23-011854
2023-06-1517:26 ET8-K/A5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001558370-23-011153
2023-06-1517:25 ET8-K/A5.07 Shareholder vote results0001558370-23-011151
2023-06-1317:20 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001558370-23-011050
2023-06-1317:15 ET8-K5.07 Shareholder vote results0001558370-23-011046
2023-05-1209:00 ET10-QQuarterly reportPeriod 2023-03-310001558370-23-009521
2023-05-1116:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-23-009363
2023-04-1717:01 ETDEF 14AProxy statement0001558370-23-006082
2023-03-1717:00 ET10-KAnnual reportPeriod 2022-12-310001558370-23-004124
2023-03-1516:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-23-003866
2023-02-1616:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001558370-23-001454
2022-11-1017:16 ET10-QQuarterly reportPeriod 2022-09-300001558370-22-017470
2022-11-1016:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-017398
2022-08-1220:02 ET10-QQuarterly reportPeriod 2022-06-300001558370-22-013383
2022-08-1016:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-013054
2022-07-1912:37 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-22-010821
2022-06-2917:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-22-010449
2022-06-0717:09 ET8-K5.07 Shareholder vote results0001558370-22-009778
2022-05-1117:04 ET10-QQuarterly reportPeriod 2022-03-310001558370-22-008347
2022-05-1016:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-008086
2022-04-1217:00 ETDEF 14AProxy statementPeriod 2022-06-030001558370-22-005327
2022-04-0108:30 ET8-K8.01 Other events0001558370-22-005003
2022-03-1120:00 ET10-KAnnual reportPeriod 2021-12-310001558370-22-003341
2022-03-1016:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-003276
2022-01-2506:01 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001558370-22-000403
2021-11-1219:00 ET10-QQuarterly reportPeriod 2021-09-300001558370-21-015571
2021-11-0916:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-015262
2021-09-2411:31 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-119139
2021-08-1309:16 ET10-QQuarterly reportPeriod 2021-06-300001558370-21-011587
2021-08-1216:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-011461
2021-07-2708:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001558370-21-009299
2021-06-2108:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-083149
2021-06-1719:00 ET8-K5.07 Shareholder vote results0001104659-21-082129
2021-05-1417:16 ET10-QQuarterly reportPeriod 2021-03-310001558370-21-007293
2021-05-1316:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-065924
2021-04-3008:01 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-21-058250
2021-04-2016:30 ETDEF 14AProxy statementPeriod 2021-06-110001104659-21-052552
2021-03-1517:27 ET10-KAnnual reportPeriod 2020-12-310001104659-21-036410
2021-03-1116:01 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-034985

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 18:39 ET. Listed shows no prices and gives no investment advice.